Does IRBESARTAN Cause Mucosal inflammation? 31 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Mucosal inflammation have been filed in association with IRBESARTAN (Irbesartan). This represents 0.3% of all adverse event reports for IRBESARTAN.
31
Reports of Mucosal inflammation with IRBESARTAN
0.3%
of all IRBESARTAN reports
19
Deaths
22
Hospitalizations
How Dangerous Is Mucosal inflammation From IRBESARTAN?
Of the 31 reports, 19 (61.3%) resulted in death, 22 (71.0%) required hospitalization, and 15 (48.4%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which IRBESARTAN Alternatives Have Lower Mucosal inflammation Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE